Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ProPhase Labs
AddedFeb 20, 2024
UpdatedJun 18, 2026
ProPhase Labs

ProPhase Labs

Public

ProPhase Labs, Inc.: Clinically-proven remedies for colds and wellness, specializing in lozenges and nutrition products.

HQ
Doylestown, PA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

ProPhase Labs, Inc. was founded with a mission to create clinically-proven remedies that enhance health and wellness. Initially known for developing zinc gluconate glycine lozenges and homeopathic gum to alleviate common cold symptoms, the company has since expanded its focus. ProPhase now operates as a next-generation biotech, genomics, and diagnostics company, offering Whole Genome Sequencing solutions and developing innovative diagnostics and therapeutics, including early detection tests for esophageal cancer.

Notable figures affiliated with ProPhase Labs include its leadership team with extensive experience in biotech and healthcare innovation. The company has attracted significant investment from industry leaders who share its vision of revolutionizing healthcare. Key achievements include the development of industry-leading genomic solutions and potentially life-saving cancer diagnostics. ProPhase Labs has made a substantial impact by advancing early detection methods and contributing to the broader field of personalized medicine.

ProPhase Labs - Similar Companies

Phase Genomics logo

Phase Genomics

phasegenomics.com

Phasiq logo

Phasiq

PhagePro logo

PhagePro

phageproinc.com

Phigenix logo

Phigenix

phigenix.com

EcoGenome logo

EcoGenome

ecogenomellc.com

Prolocor logo

Prolocor

prolocor.com

Phdx logo

Phdx

Proteotech logo

Proteotech

Phenomune logo

Phenomune

phenomune.com

PrognomiQ logo

PrognomiQ

prognomiq.com

PhageTech logo

PhageTech

phagetech.com

Probius logo

Probius

probius.bio

PrognosDx Health logo

PrognosDx Health

ProstaGene logo

ProstaGene

Protean Biodiagnostics logo

Protean Biodiagnostics

proteanbiodx.com

ProPhase Labs - Quick Facts

Who are ProPhase Labs' competitors?

Companies similar to ProPhase Labs include Phase Genomics, Phasiq, PhagePro and Phigenix.

When was ProPhase Labs founded?

ProPhase Labs was founded in 2015.

Where is ProPhase Labs' headquarters located?

ProPhase Labs' headquarters is located in Doylestown, PA, US.

When was ProPhase Labs' last funding round?

ProPhase Labs' most recent funding round was for $7M (USD) in January 2014.

How much has ProPhase Labs raised to-date?

As of Jan 1, 2014, ProPhase Labs has raised a total of $7M (USD).

How many employees does ProPhase Labs have?

ProPhase Labs has 129 employees as of Feb 5, 2024.

ProPhase Labs - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
  • Genomics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Diagnostics
  • Therapeutics
Tags
  • Healthtech
Unique IDs
  • ein: 232577138
  • secCik: 0000868278
  • ticker: PRPH
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 7 more industry codes
NAICS
  • 326000Plastics and Rubber Products Manufacturing
  • 326100Plastics Product Manufacturing
  • 326190Other Plastics Product Manufacturing
  • 326199All Other Plastics Product Manufacturing
SIC
  • 3000Rubber And Miscellaneous Plastics Products
  • 3080Miscellaneous Plastics Products
  • 3089Plastics Products, Not Elsewhere Classified